A detailed history of Lantern Wealth Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lantern Wealth Advisors, LLC holds 14,680 shares of BMY stock, worth $864,211. This represents 0.53% of its overall portfolio holdings.

Number of Shares
14,680
Previous 13,478 8.92%
Holding current value
$864,211
Previous $560 Million 35.7%
% of portfolio
0.53%
Previous 0.41%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $47,671 - $62,203
1,202 Added 8.92%
14,680 $760 Million
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $57,638 - $75,881
1,432 Added 11.89%
13,478 $560 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $6,813 - $7,724
142 Added 1.19%
12,046 $653 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $577,105 - $688,646
11,904 New
11,904 $611 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lantern Wealth Advisors, LLC Portfolio

Follow Lantern Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lantern Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lantern Wealth Advisors, LLC with notifications on news.